ArticleScientific reports2025
Elevated pulse wave velocity as a marker of arterial stiffness and its association with mortality in US adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Association of Estimated Pulse Wave Velocity with Chronic Kidney Disease Risk: A Machine Learning Analysis Based on NHANES and CHARLS.Healthcare (Basel, Switzerland) · 2026Article
- Average Real Variability Is an Independent Predictor of Increased Arterial Stiffness Assessed by Pulse Wave Velocity.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Association of estimated pulse wave velocity with non-alcoholic fatty liver disease in multiple cohorts.iScience · 2026Article
- Association of vascular aging and insulin resistance with cardiovascular outcomes in China: PURE cohort study.International journal of surgery (London, England) · 2026Article
- Cardiovascular disease burden in children with obesity: A narrative review.International journal of cardiology. Cardiovascular risk and prevention · 2026Review
- The Emerging Role of Mechanobiology in Connecting Metabolic and Cardiovascular Diseases: From Fundamentals to Future Therapies.Biomedicines · 2026Review
- Ultrasound in cardiovascular care: a perspective on preventive, diagnostic, and monitoring applications.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Estimated pulse wave velocity (ePWV) has been proposed as a potential substitute for carotid-femoral pulse wave velocity (cfPWV), serving as an indicator for assessing aortic stiffness. Arterial stiffness has emerged as a potential marker associated with adverse outcomes in various specific diseases, yet its relationship with mortality rates in the general adult population remains unstudied. This study aims to investigate the association between arterial stiffness and both all-cause and cardiovascular mortality among US adults. Data from 48,257 participants aged 20 and older in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018 were analyzed. Mortality details were obtained from the National Death Index (NDI). Restricted cubic spline (RCS) functions were used to visualize the association between estimated pulse wave velocity (ePWV) and mortality risk. Weighted Cox proportional hazards models were employed to assess the independent correlation between ePWV and mortality risk. Time-dependent receiver operating characteristic (ROC) curve analysis was conducted to evaluate the predictive ability of ePWV for survival. Further subgroup analyses were performed to validate the robustness of the associations. Participants were stratified into higher (> 10.92) and lower (≤ 10.92) ePWV groups. During a median follow-up of 133.69 ± 94.42 months, 8029 (16.6%) deaths, including 2641 (5.5%) cardiovascular deaths, occurred among the 48,257 participants. The weighted Cox proportional hazards model showed that after comprehensive adjustment for covariates, individuals with higher ePWV had significantly increased risks of all-cause mortality (HR 2.67, 95% confidence interval [CI] 2.50-2.84, P < 0.001) and cardiovascular mortality (HR 2.75, 95%CI 2.46-3.07, P < 0.001). RCS regression analysis revealed a nonlinear association between ePWV, a marker of arterial stiffness, and all-cause mortality with an inflection point at 8.267 (P for nonlinear = 0.0001), while a positive linear correlation was observed with cardiovascular mortality (P for nonlinear = 0.889). This association was consistent across subgroups based on age, gender, race, body mass index, education level, marital status, smoking, alcohol consumption, diabetes, and hypertension, with significant interactions observed for all-cause mortality in the hypertension subgroup (P for interaction = 0.012) and for cardiovascular mortality in smoking (P for interaction = 0.032), diabetes (P for interaction < 0.001), and hypertension subgroups (P for interaction = 0.012). The time-dependent ROC curves indicated areas under the curve (AUCs) of 0.73, 0.80, and 0.79 for 1-year, 6-year, and 10-year survival rates, respectively, for all-cause mortality, and 0.85, 0.83, and 0.83 for cardiovascular mortality. Elevated ePWV is independently associated with increased cardiovascular mortality in US adults and exhibits a significant positive correlation with all-cause mortality in US adults beyond an ePWV threshold of 8.267.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.